Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > Articles online first > The Journal of Cardiovascular Surgery 2015 Sep 29



Per citare questo articolo


Rivista di Chirurgia Cardiaca, Vascolare e Toracica

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179



The Journal of Cardiovascular Surgery 2015 Sep 29


lingua: Inglese

The endovascular treatment of juxta-renal abdominal aortic aneurysm using fenestrated endograft: early and mid-term results

Gallitto E., Gargiulo M., Freyrie A., Mascoli C., Massoni Bianchini C., Ancetti S., Faggioli G., Stella A.

Vascular Surgery, University of Bologna, Azienda Policlinico S. Orsola-Malpighi


AIM: To evaluate the early and mid term results of the endovascular treatment of juxta-renal abdominal aortic aneurysms (j-AAA) using fenestrated endograft (FEVAR).
METHODS: Between 2008 to 2013 all consecutive patients underwent FEVAR using Cook-Zenith fenestrated endograft for treating j-AAA (proximal neck length <5mm) with renal aortic α/β angle < 60°, were prospectively collected in a database. Cardiovascular risk factors, co-morbidities, aortic- iliac morphological features, intra and post-procedural data were analyzed. Pre-operative FEVAR planning was performed by a thoraco-abdominal computer tomography angiography (CTA) and the 3D/Center Lumen Line reconstructions (3Mensio). Follow-up was conduced by duplex ultrasound (DUS)/ contrast enhancement DUS (CEUS) and/or CTA at 1,6,12-month and yearly thereafter. Early endpoints were: technical (TS) / clinical (CS) success, renal function worsening (≥ 30% of pre- operative creatinine value) and type I/III endoleak. Mid term endpoints were: type I/III endoleak, target visceral vessels patency, j-AAA shrinkage, freedom from re-intervention and survival.
RESULTS: Twenty patients (M: 94.7%; mean age: 73.4±5.9 years; ASA ≥3: 100%) were enrolled. The mean neck length and j-AAA diameter were 2 ± 1.4mm (range: 0-4mm) and 54.9 ±5mm respectively. Eleven (55%) endograft with 2 fenestrations and a scallop, 8 (45%) with 3 fenestrations and a scallop and 1 (5%) with 1 fenestration and a scallop were implanted. Sixty-seven visceral vessels were re-vascularized. TS and CS were 100% and 95% respectively (1/20 30-day mortality). Peri-operative renal function worsening was observed in 15% of cases. The mean follow-up was 25±20 months (range: 2-72months). No type I/III endoleak or occlusion of target visceral vessels occurred. There was j-AAA shrinkage in 65% of patients and no cases of j-AAA enlargement were observed. There were no FEVAR-related re-interventions. Survival at 12, 24 and 36 months were 89.4%, 80.5% e 80.5% respectively.
CONCLUSION: According to our results, the endovascular treatment for j-AAA, with α/β angle < 60°, is safe and effective.

inizio pagina

Publication History

Per citare questo articolo

Gallitto E, Gargiulo M, Freyrie A, Mascoli C, Massoni Bianchini C, Ancetti S, et al. The endovascular treatment of juxta-renal abdominal aortic aneurysm using fenestrated endograft: early and mid-term results. J Cardiovasc Surg 2015 Sep 29. 

Corresponding author e-mail